International legal practice Osborne Clarke has represented the founders and INKEF Capital, Gilde Healthcare, Thuja Capital Healthcare, Health Innovation Fund, Van Herk Ventures (sellers) in the sale of NightBalance to Royal Philips. NightBalance is a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring.
NightBalance’s Sleep Position Trainer (SPT) was designed as a comfortable and easy to use treatment alternative for people who suffer from positional obstructive sleep apnea. The SPT gently prompts them not to sleep on their back, avoiding the apneas from occurring during sleep. The SPT is CE-marked and is currently marketed in select countries in Europe.
“We founded NightBalance in 2009 with the ambition to improve the lives of positional apnea patients worldwide”, said Eline Vrijland-van Beest, CEO of NightBalance. “I am proud that our innovation is in good hands with Philips. Their strength in connected sleep therapy solutions and global reach will accelerate the accessibility of the Sleep Position Trainer”.
The Osborne Clarke in Amsterdam team was led by Herke van Hulst and consisted of Marie-Louise Weeda, Guusje Cornelissen and Coen Barneveld Binkhuysen.
Osborne Clarke’s market leading venture capital team is considered a go-to practice. The team across Europe, Asia and the US combine extensive market knowledge and deep sector expertise to support companies throughout all stages of their developments, from start-up to later stage and growth capital funding, strategic M&A and exits, acting for founders, companies, and financial and strategic investors. The team has particular expertise in the tech, media and comms, financial services and life sciences sectors.